Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Please stand by. Welcome, ladies and gentlemen, to the fourth quarter and full year 2025 earnings conference call for OrganiGenesis Holding Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risk and uncertainties that it could cause actual results to differ materially from those indicated, including the risk and uncertainties described in the company's filings with the Securities and Exchange Commission, including Item 1A, Risk Factors, of the company's most recent annual report and its subsequently filed quarterly report. You are cautioned not to place undue reliance upon any forward-looking statements which speak only as of the date made. Although it may voluntarily do so from time to time, the company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by applicable security laws. This call will also include references to certain financial measures that are not calculated in accordance with the generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliation of these non-GAAP financial measures to the most comparable measures calculated in accordance with GAAP are available in the company's earnings release on the investor relations portion of our website. I would now like to turn the call over to Mr. Gary S. Goheni, Sr., organogenesis holdings ...